OncoCyte Corporation (NASDAQ: OCX) reported Q1 EPS of $0.04, $0.12 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $457 thousand.

For earnings history and earnings-related data on OncoCyte Corporation (OCX) click here.